Advanced Biomedical Technologies, Inc.
ABMT · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 58.3% | 38.5% | 960.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 81.9% | 54.5% | 58.1% | 34.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -66.4% | -230.7% | -361.4% | -5,187.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -190.2% | -426.1% | -543.7% | -8,139.5% |
| EPS | -0.007 | -0.01 | -0.01 | -0.01 |
| % Growth | 29.8% | -8.3% | 4% | – |
| EPS Diluted | -0.007 | -0.01 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 71 | 70 | 70 | 70 |
| Weighted Avg Shares Out Dil | 71 | 70 | 70 | 70 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | -61.3% | -214.6% | -228.7% | -5,158% |